-
2
-
-
67650083500
-
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: Advantages of the heterologous DNA prime, protein boost immunization regimen
-
Alekseeva E, Sominskaya I, Skrastina D, Egorova I, Starodubova E, Kushners E, Mihailova M, Petrakova N, Bruvere R, Kozlovskaya T, Isaguliants M, Pumpens P (2009) Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther 7: 7.
-
(2009)
Genet Vaccines Ther
, vol.7
, pp. 7
-
-
Alekseeva, E.1
Sominskaya, I.2
Skrastina, D.3
Egorova, I.4
Starodubova, E.5
Kushners, E.6
Mihailova, M.7
Petrakova, N.8
Bruvere, R.9
Kozlovskaya, T.10
Isaguliants, M.11
Pumpens, P.12
-
3
-
-
60349132278
-
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial
-
Alvarez-Lajonchere L, Shoukry NH, Gra B, Amador-Canizares Y, Helle F, Bedard N, Guerra I, Drouin C, Dubuisson J, Gonzalez-Horta EE, Martinez G, Marante J, Cinza Z, Castellanos M, Duenas-Carrera S (2009) Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. J Viral Hepat 16: 156-167.
-
(2009)
J Viral Hepat
, vol.16
, pp. 156-167
-
-
Alvarez-Lajonchere, L.1
Shoukry, N.H.2
Gra, B.3
Amador-Canizares, Y.4
Helle, F.5
Bedard, N.6
Guerra, I.7
Drouin, C.8
Dubuisson, J.9
Gonzalez-Horta, E.E.10
Martinez, G.11
Marante, J.12
Cinza, Z.13
Castellanos, M.14
Duenas-Carrera, S.15
-
4
-
-
68949148580
-
Long-term outcomes after treatment with interferon and ribavirin in HCV patients
-
Aronsohn A, Reau N (2009) Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol 43: 661-671.
-
(2009)
J Clin Gastroenterol
, vol.43
, pp. 661-671
-
-
Aronsohn, A.1
Reau, N.2
-
5
-
-
70149083221
-
-
Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L (2009) Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev 3: 1469-1493.
-
-
-
-
6
-
-
70350633739
-
The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen
-
Bolhassani A, Ghasemi N, Servis C, Taghikhani M, Rafati S (2009) The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen. Drug Deliv 16: 196-204.
-
(2009)
Drug Deliv
, vol.16
, pp. 196-204
-
-
Bolhassani, A.1
Ghasemi, N.2
Servis, C.3
Taghikhani, M.4
Rafati, S.5
-
7
-
-
23944481107
-
Unscrambling hepatitis C virus-host interactions
-
Chisari FV (2005) Unscrambling hepatitis C virus-host interactions. Nature 436: 930-932.
-
(2005)
Nature
, vol.436
, pp. 930-932
-
-
Chisari, F.V.1
-
8
-
-
34247612265
-
Flying under the radar: The immunobiology of hepatitis C
-
Dustin LB, Rice CM (2007) Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 25: 71-99.
-
(2007)
Annu Rev Immunol
, vol.25
, pp. 71-99
-
-
Dustin, L.B.1
Rice, C.M.2
-
9
-
-
60349120039
-
Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy
-
Fujino T, Nakamuta M, Aoyagi Y, Fukuizumi K, Takemoto R, Yoshimoto T, Miyahara T, Harada N, Sakai H, Nakashima M, Enjoji M (2009) Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy. J Dig Dis 10: 21-25.
-
(2009)
J Dig Dis
, vol.10
, pp. 21-25
-
-
Fujino, T.1
Nakamuta, M.2
Aoyagi, Y.3
Fukuizumi, K.4
Takemoto, R.5
Yoshimoto, T.6
Miyahara, T.7
Harada, N.8
Sakai, H.9
Nakashima, M.10
Enjoji, M.11
-
10
-
-
62949086945
-
Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection
-
Guglietta S, Garbuglia AR, Salichos L, Ruggeri L, Folgori A, Perrone MP, Camperio C, Mellace V, Maio G, Maio P, Capobianchi MR, Spada E, Gargano N, Scotta C, Piccolella E, Del Porto P (2009) Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection. Virology 386: 398-406.
-
(2009)
Virology
, vol.386
, pp. 398-406
-
-
Guglietta, S.1
Garbuglia, A.R.2
Salichos, L.3
Ruggeri, L.4
Folgori, A.5
Perrone, M.P.6
Camperio, C.7
Mellace, V.8
Maio, G.9
Maio, P.10
Capobianchi, M.R.11
Spada, E.12
Gargano, N.13
Scotta, C.14
Piccolella, E.15
Del Porto, P.16
-
11
-
-
68949101391
-
-
Hewlett AT (2009) Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis. Expert Opin Biol Ther 9: 1235-1240.
-
-
-
-
12
-
-
70349263804
-
-
Iwasa M, Hara N, Miyachi H, Tanaka H, Takeo M, Fujita N, Kobayashi Y, Kojima Y, Kaito M, Takei Y (2009) Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels. J Viral Hepat 16: 716-723.
-
-
-
-
13
-
-
0036788253
-
Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C
-
Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW (2002) Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123: 1070-1083.
-
(2002)
Gastroenterology
, vol.123
, pp. 1070-1083
-
-
Kamal, S.M.1
Fehr, J.2
Roesler, B.3
Peters, T.4
Rasenack, J.W.5
-
14
-
-
49749125576
-
Evaluation of operational chronic infection endpoints for HCV vaccine trials
-
Kang M, Nicolay U (2008) Evaluation of operational chronic infection endpoints for HCV vaccine trials. Contemp Clin Trials 29: 671-678.
-
(2008)
Contemp Clin Trials
, vol.29
, pp. 671-678
-
-
Kang, M.1
Nicolay, U.2
-
15
-
-
17144396869
-
Host cell targets in HCV therapy: Novel strategy or proven practice?
-
Klebl BM, Kurtenbach A, Salassidis K, Daub H, Herget T (2005) Host cell targets in HCV therapy: novel strategy or proven practice? Antivir Chem Chemother 16: 69-90.
-
(2005)
Antivir Chem Chemother
, vol.16
, pp. 69-90
-
-
Klebl, B.M.1
Kurtenbach, A.2
Salassidis, K.3
Daub, H.4
Herget, T.5
-
16
-
-
0035860626
-
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
-
Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A (2001) Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19: 4652-4660.
-
(2001)
Vaccine
, vol.19
, pp. 4652-4660
-
-
Livingston, B.D.1
Newman, M.2
Crimi, C.3
McKinney, D.4
Chesnut, R.5
Sette, A.6
-
17
-
-
0029968531
-
Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules
-
Newberg MH, Smith DH, Haertel SB, Vining DR, Lacy E, Engelhard VH (1996) Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J Immunol 156: 2473-2480.
-
(1996)
J Immunol
, vol.156
, pp. 2473-2480
-
-
Newberg, M.H.1
Smith, D.H.2
Haertel, S.B.3
Vining, D.R.4
Lacy, E.5
Engelhard, V.H.6
-
18
-
-
67649933266
-
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles
-
Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S (2009) A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles. J Med Virol 81: 1232-1240.
-
(2009)
J Med Virol
, vol.81
, pp. 1232-1240
-
-
Niu, Y.1
Komatsu, N.2
Komohara, Y.3
Matsueda, S.4
Yutani, S.5
Ishihara, Y.6
Itou, M.7
Yamada, A.8
Itoh, K.9
Shichijo, S.10
-
19
-
-
47149087508
-
Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys
-
Park SH, Lee SR, Hyun BH, Kim BM, Sung YC (2008) Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys. Vaccine 26: 3978-3983.
-
(2008)
Vaccine
, vol.26
, pp. 3978-3983
-
-
Park, S.H.1
Lee, S.R.2
Hyun, B.H.3
Kim, B.M.4
Sung, Y.C.5
-
21
-
-
17844371667
-
Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection
-
Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A, Klenerman P (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41: 1019-1028.
-
(2005)
Hepatology
, vol.41
, pp. 1019-1028
-
-
Semmo, N.1
Day, C.L.2
Ward, S.M.3
Lucas, M.4
Harcourt, G.5
Loughry, A.6
Klenerman, P.7
-
22
-
-
3543075211
-
Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs
-
Shi TD, Wu YZ, Jia ZC, Zou LY, Zhou W (2004) Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs. World J Gastroenterol 10: 1902-1906.
-
(2004)
World J Gastroenterol
, vol.10
, pp. 1902-1906
-
-
Shi, T.D.1
Wu, Y.Z.2
Jia, Z.C.3
Zou, L.Y.4
Zhou, W.5
-
23
-
-
2942652411
-
Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses
-
Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA (2004) Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol 78: 7052-7060.
-
(2004)
J Virol
, vol.78
, pp. 7052-7060
-
-
Snyder, J.T.1
Belyakov, I.M.2
Dzutsev, A.3
Lemonnier, F.4
Berzofsky, J.A.5
-
24
-
-
32644490562
-
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
-
Thimme R, Lohmann V, Weber F (2006) A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res 69: 129-141.
-
(2006)
Antiviral Res
, vol.69
, pp. 129-141
-
-
Thimme, R.1
Lohmann, V.2
Weber, F.3
-
25
-
-
58949097368
-
Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha
-
Wan L, Kung YJ, Lin YJ, Liao CC, Sheu JJ, Tsai Y, Lai HC, Peng CY, Tsai FJ (2009) Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha. Biochem Biophys Res Commun 379: 855-860.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 855-860
-
-
Wan, L.1
Kung, Y.J.2
Lin, Y.J.3
Liao, C.C.4
Sheu, J.J.5
Tsai, Y.6
Lai, H.C.7
Peng, C.Y.8
Tsai, F.J.9
-
26
-
-
67650173025
-
Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4
-
Wang YC, Hu XB, He F, Feng F, Wang L, Li W, Zhang P, Li D, Jia ZS, Liang YM, Han H (2009) Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4. J Biol Chem 284: 15993-16003.
-
(2009)
J Biol Chem
, vol.284
, pp. 15993-16003
-
-
Wang, Y.C.1
Hu, X.B.2
He, F.3
Feng, F.4
Wang, L.5
Li, W.6
Zhang, P.7
Li, D.8
Jia, Z.S.9
Liang, Y.M.10
Han, H.11
-
27
-
-
44449157563
-
A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen
-
Wei SH, Yin W, An QX, Lei YF, Hu XB, Yang J, Lu X, Zhang H, Xu ZK (2008) A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen. Arch Virol 153: 1021-1029.
-
(2008)
Arch Virol
, vol.153
, pp. 1021-1029
-
-
Wei, S.H.1
Yin, W.2
An, Q.X.3
Lei, Y.F.4
Hu, X.B.5
Yang, J.6
Lu, X.7
Zhang, H.8
Xu, Z.K.9
-
29
-
-
33748301260
-
Global challenges in liver disease
-
Williams R (2006) Global challenges in liver disease. Hepatology 44: 521-526.
-
(2006)
Hepatology
, vol.44
, pp. 521-526
-
-
Williams, R.1
-
30
-
-
70349507292
-
-
Wolters B, Muller T, Ross RS, Clauberg R, Werfel U, Roggendorf H, Siggelkow C, Hausen T, Roggendorf M (2009) Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial. Hum Vaccin 5: 248-253.
-
-
-
-
31
-
-
10444223015
-
Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line
-
Yang M, Zhu F, Sonderstrup G, Eckels DD (2005) Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line. Vaccine 23: 951-962.
-
(2005)
Vaccine
, vol.23
, pp. 951-962
-
-
Yang, M.1
Zhu, F.2
Sonderstrup, G.3
Eckels, D.D.4
-
32
-
-
33847182484
-
Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice
-
Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lu X, Yang J, Su M, Xu Z, Hao X (2007) Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. J Virol Methods 141: 41-48.
-
(2007)
J Virol Methods
, vol.141
, pp. 41-48
-
-
Yue, Q.1
Hu, X.2
Yin, W.3
Xu, X.4
Wei, S.5
Lei, Y.6
Lu, X.7
Yang, J.8
Su, M.9
Xu, Z.10
Hao, X.11
-
33
-
-
69249221321
-
A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice
-
Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L (2009) A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Antiviral Res 84: 23-30.
-
(2009)
Antiviral Res
, vol.84
, pp. 23-30
-
-
Zeng, R.1
Li, G.2
Ling, S.3
Zhang, H.4
Yao, Z.5
Xiu, B.6
He, F.7
Huang, R.8
Wei, L.9
|